Article
Treatment of two patients with Herlitz junctional epidermolysis bullosa with artificial skin bioequivalents.
The Journal of pediatrics - 1 Oct 2002
Jiang Qiu-Jie, Izakovic Jan, Zenker Martin, Fartasch Manige, Meneguzzi Guerrino, Rascher Wolfgang, Schneider Holm
Abstract excerpt
OBJECTIVE: To evaluate the effects of a treatment with artificial skin bioequivalents in Herlitz junctional epidermolysis bullosa (H-JEB). METHODS: Two infants, both homozygous for the Herlitz mutation R635X in the LAMB3 gene, who had refractory anemia and hypoproteinemia as a result of a continuous loss of body fluids through multiple large erosions, were treated with artificial skin bioequivalents. RESULTS: In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
